Funding Opportunity Number: RFA-DK-26-009
Deadlines
Letter of Intent: May 26, 2025
Submission: June 26, 2025
Background
Type 1 diabetes (T1D) is an autoimmune disease that destroys insulin-producing cells in the pancreas. The loss of proper glucose control that ensues leads to a variety of pathologic consequences, including complications affecting the heart, eye, nerves, kidney and urogenital systems. While the incidence of T1D is increasing worldwide, research continues into the underlying mechanisms contributing to disease onset and severity, and into the development of therapies to effectively prevent or intervene in the disease process.
The Gateway Award in T1D Research is designed to ensure a robust pipeline of innovative research and talented new investigators in T1D research. In addition to providing support for preliminary research, the Gateway program provides an opportunity for new investigators to pursue their studies within the intellectual environment of a select number of large, ongoing collaborative research programs. Embedding awardees within the established scientific framework afforded by each of these consortia will provide unique opportunities for New Investigators (NI) and Early Stage Investigators (ESI) to increase their understanding of key questions in the field, and for networks to benefit from new ideas and diverse perspectives.
Objectives and Scope
The Gateway Award in T1D research supports New Investigators and Early Stage Investigators who are interested in pursuing careers in T1D, including qualified researchers from diverse scientific backgrounds. The goal of the program is to provide support for high quality innovative and significant research by junior faculty engaged in basic, translational and clinical research that will firmly establish the awardees in a T1D-oriented career path and set the stage for competitive first R01 submissions.
For more information, please see the opportunity webpage.